|
|
Arch Dis Child. 1978 April; 53(4): 319–321. | PMCID: PMC1544893 |
Value of serum ferritin estimation in sickle cell anaemia. M A Hussain, L R Davis, M Laulicht, and A V Hoffbrand Abstract In a group of 35 children with sickle cell anaemia serum ferritin concentration ranged from 70 to 2460 microgram/l (mean 367, median 180 microgram/l). This was significantly higher than the ferritin levels (range 8-101, mean 34, median 30 microgram/l) in a group of 63 normal control children of the same age group. 30 (86%) of the sickle cell children showed serum ferritin levels greater than 101 microgram/l, and 2 (6%) levels greater than 1000 microgram/l. 7 of the patients had not been transfused before this study. Their serum ferritin levels were all raised and showed a significant correlation with age but not with haemoglobin level. In the remainder of the patients the serum ferritin bore no significant correlation with age, haemoglobin level, or number of units of blood transfused. 2 children with HbSC disease had levels within the control range. Since patients with sickle cell anaemia have an increasing chance of long survival, we suggest that serial estimations of their iron status be made by means of serum ferritin assay in order to determine which patients are accumulating excessive iron. Full text Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (431K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References. These references are in PubMed. This may not be the complete list of references from this article. - Addison GM, Beamish MR, Hales CN, Hodgkins M, Jacobs A, Llewellin P. An immunoradiometric assay for ferritin in the serum of normal subjects and patients with iron deficiency and iron overload. J Clin Pathol. 1972 Apr;25(4):326–329. [PubMed]
- ERLANDSON ME, WALDEN B, STERN G, HILGARTNER MW, WEHMAN J, SMITH CH. Studies on congenital hemolytic syndromes, IV. Gastrointestinal absorption of iron. Blood. 1962 Mar;19:359–378. [PubMed]
- Hussain MA, Green N, Flynn DM, Hussein S, Hoffbrand AV. Subcutaneous infusion and intramuscular injection of desferrioxamine in patients with transfusional iron overload. Lancet. 1976 Dec 11;2(7998):1278–1280. [PubMed]
- Hussain MA, Green N, Flynn DM, Hoffbrand AV. Effect of dose, time, and ascorbate on iron excretion after subcutaneous desferrioxamine. Lancet. 1977 May 7;1(8019):977–979. [PubMed]
- Lincoln TL, Aroesty J, Morrison P. Iron-deficiency anemia and sickle-cell disease: a hypothesis. Lancet. 1973 Aug 4;2(7823):260–261. [PubMed]
- Peterson CM, Graziano JH, de Ciutiis A, Grady RW, Cerami A, Worwood M, Jacobs A. Iron metabolism, sickle cell disease, and response to cyanate. Blood. 1975 Oct;46(4):583–590. [PubMed]
- Propper RD, Shurin SB, Nathan DG. Reassessment of the use of desferrioxamine B in iron overload. N Engl J Med. 1976 Jun 24;294(26):1421–1423. [PubMed]
- Siimes MA, Addiego JE, Jr, Dallman PR. Ferritin in serum: diagnosis of iron deficiency and iron overload in infants and children. Blood. 1974 Apr;43(4):581–590. [PubMed]
|
This article has been